Adam Mead is the founder of KARV, a brand consultancy helping pharma and biotech organizations go from pitching in data and infomation to sharing a human-centric story — from clinical differentiation to commercial launch. With nearly two decades of experience and deep roots in pharma manufacturing, Adam has partnered with organizations including Phlow (small molecule API/CDMO), Indivior (global pharma), and Miltenyi Bioindustry (global CGT CDMO) to build narratives that resonate across stakeholders — from scientific teams to investors to commercial partners. At CPHI, Adam is connecting with CDMOs and contract organizations supporting the pharma and biotech industry who are ready to articulate their value with the clarity and conviction that wins partnerships and drives growth.